FDA Approves Unknown Drug — SPECGX LLC
SPECGX LLC has announced the FDA approval of its Generic ANDA075983, gaining the rights to distribute this unbranded pharmaceutical substance. This clearance opens a new lucrative channel for the company by enabling the immediate commercialization of a generic drug in the market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed